Expression of the CTLA-4 ligand CD86 on plasmacytoid dendritic cells (pDC) predicts risk of disease recurrence after treatment discontinuation in CMLChristin Schütz, Andreas Burchert, S Sausslele et al.|Leukemia|2017Cited by 106